Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic

Jun-24

AUTHORS : Miguel A. Salinero-Fort, Department of Health, Foundation for Biosanitary Research and Innovation in Primary Care, The Hospital La Paz Institute for Health Research (IdiPAZ), Alfonso X El Sabio University, Research Network On Chronicity, Primary Care and Health Promotion -RICAPPS-(RICORS), General Subdirectorate of Research and Documentation, Madrid, Spain

JOURNAL : BMC

REFERENCE: (2024) 24:533

DOI : 10.1186/s12877-024-05149-0

Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic

More publications

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer’s, Parkinson’s and dementia at age 65: a study using medical records from France and the UK General Practitioners

Association between tramadol use and risk of pneumonia in the middle-aged and elderly populations: a propensity-score matched cohort study

Incidence of Recorded Osteoporosis, Osteopenia and Fragility Fracture in Older People: Analysis of UK Primary Care Data